Search research articles
Contact Us
Filters
Showing results (221-230 of 547) with videos related to
Page
of 55
Sort By:
Journal of Cellular Physiology
|
March 11, 2011
Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR
Daniela Berg, Claudia Wolff, Katharina Malinowsky, et al.
NPJ Parkinson'S Disease
|
May 9, 2025
The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathies
Sinah Röttgen, Eva Schaeffer, Annette Rogge, et al.
Journal of Alzheimer'S Disease : JAD
|
December 5, 2012
Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients
Christoph Laske, Michael Schmohl, Thomas Leyhe, et al.
The FEBS Journal
|
November 10, 2009
Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways
Daniela Berg, Thorsten Stühmer, Daniela Siegmund, et al.
Neurobiology of Disease
|
December 26, 2006
Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model
Walter Maetzler, Daniela Berg, Natalie Schalamberidze, et al.
Cells
|
July 11, 2025
Neurofilament Light Chain in Serum and CSF as a Potential Biomarker for Primary Angiitis of the Central Nervous System
Christina Krüger, Hans Pinnschmidt, Maximilian Wilmes, et al.
Alzheimer'S Research & Therapy
|
March 28, 2026
Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment
Jonathan Merkel, Robert Perneczky, Frank Jessen, et al.
Neuroimage
|
February 22, 2003
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease
Petra Ruprecht-Dörfler, Daniela Berg, Oliver Tucha, et al.
Plos One
|
February 19, 2013
Illicit stimulant use is associated with abnormal substantia nigra morphology in humans
Gabrielle Todd, Carolyn Noyes, Stanley C Flavel, et al.
Parkinsonism & Related Disorders
|
April 14, 2018
A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members
Marija Dulovic, Eva Schäffer, Frank Leypoldt, et al.
Page
of 55
Search research articles
Search
Showing results (221-230 of 547) with videos related to
Sort By:
Page
of 55
Journal of Cellular Physiology
|
March 11, 2011
Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR
Daniela Berg, Claudia Wolff, Katharina Malinowsky, et al.
NPJ Parkinson'S Disease
|
May 9, 2025
The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathies
Sinah Röttgen, Eva Schaeffer, Annette Rogge, et al.
Journal of Alzheimer'S Disease : JAD
|
December 5, 2012
Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients
Christoph Laske, Michael Schmohl, Thomas Leyhe, et al.
The FEBS Journal
|
November 10, 2009
Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways
Daniela Berg, Thorsten Stühmer, Daniela Siegmund, et al.
Neurobiology of Disease
|
December 26, 2006
Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model
Walter Maetzler, Daniela Berg, Natalie Schalamberidze, et al.
Cells
|
July 11, 2025
Neurofilament Light Chain in Serum and CSF as a Potential Biomarker for Primary Angiitis of the Central Nervous System
Christina Krüger, Hans Pinnschmidt, Maximilian Wilmes, et al.
Alzheimer'S Research & Therapy
|
March 28, 2026
Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment
Jonathan Merkel, Robert Perneczky, Frank Jessen, et al.
Neuroimage
|
February 22, 2003
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease
Petra Ruprecht-Dörfler, Daniela Berg, Oliver Tucha, et al.
Plos One
|
February 19, 2013
Illicit stimulant use is associated with abnormal substantia nigra morphology in humans
Gabrielle Todd, Carolyn Noyes, Stanley C Flavel, et al.
Parkinsonism & Related Disorders
|
April 14, 2018
A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members
Marija Dulovic, Eva Schäffer, Frank Leypoldt, et al.
Page
of 55